Background Early screening may prevent fibrosis progression in metabolic‐associated fatty
liver disease (MAFLD). Aims We developed and validated MAFLD fibrosis score (MFS) for …

Methods The NHANES 2017-2018 datasets were used to compare the performances of
different noninvasive fibrosis scores in MAFLD, including the aspartate aminotransferase …

Methods The analysis included a total of 8317 individuals who had complete biochemical
and liver ultrasonography data from the National Health and Nutrition Examination Survey …

Background & Aims Metabolic dysfunction–associated fatty liver disease (MAFLD) is
managed predominately in primary care, however, there is uncertainty regarding how to best …

BACKGROUND Non-invasive fibrosis scores are not yet validated in the newly defined
metabolic associated fatty liver disease (MAFLD). AIM To evaluate the diagnostic …

Abstract Background & Aims Diagnostic criteria for metabolic associated fatty liver disease
(MAFLD) have been proposed, but not validated. We aimed to compare the diagnostic …

Metabolic dysfunction-associated fatty liver disease (MAFLD) may progress to advanced
liver fibrosis (ALF). We evaluated the diagnostic accuracy of a novel Liver Fibrosis Risk …

Methods A total of 560 patients (28 lean, 174 overweight, 229 obese, 89 severely obese, 40
morbidly obese) were included. Diagnostic performances and optimal cut-off values for FIB …

The purpose of this study was to explore the correlation between Hashimoto's thyroiditis and
Metabolic dysfunction-associated fatty liver disease (MAFLD), and at the same time to …

Abstract Aims Fibrosis‐4 index (FIB‐4) and non‐alcoholic fatty liver disease (NAFLD)
fibrosis score (NFS) are the two most widely used non‐invasive tools for screening of …